Bruce N. Cronstein, MD

Bruce N. Cronstein, MD
New York University School of Medicine, New York

Correspondence: Bruce N. Cronstein, MD, Professor of Medicine and Pathology, Director, Division of Clinical Pharmacology, Associate Chairman of Medicine for Research, NYU School of Medicine, 550 First Ave, New York, NY 10016; e-mail: [email protected]

The author has indicated that he has received grant or research support from King Pharmaceuticals, has been a consultant for Merck, and is on the speakers’ bureaus of Merck and Amgen.

Bruce N. Cronstein, MD
New York University School of Medicine, New York

Correspondence: Bruce N. Cronstein, MD, Professor of Medicine and Pathology, Director, Division of Clinical Pharmacology, Associate Chairman of Medicine for Research, NYU School of Medicine, 550 First Ave, New York, NY 10016; e-mail: [email protected]

The author has indicated that he has received grant or research support from King Pharmaceuticals, has been a consultant for Merck, and is on the speakers’ bureaus of Merck and Amgen.

Bruce N. Cronstein, MD
New York University School of Medicine, New York

Correspondence: Bruce N. Cronstein, MD, Professor of Medicine and Pathology, Director, Division of Clinical Pharmacology, Associate Chairman of Medicine for Research, NYU School of Medicine, 550 First Ave, New York, NY 10016; e-mail: [email protected]

The author has indicated that he has received grant or research support from King Pharmaceuticals, has been a consultant for Merck, and is on the speakers’ bureaus of Merck and Amgen.